Free Trial

IMAC (IMAC) Competitors

IMAC logo
$1.27 -0.03 (-2.35%)
As of 01/10/2025

IMAC vs. FTLF, CGEN, SAVA, SEER, NVRO, NBTX, ZJYL, BMEA, NOTV, and XBIT

Should you be buying IMAC stock or one of its competitors? The main competitors of IMAC include FitLife Brands (FTLF), Compugen (CGEN), Cassava Sciences (SAVA), Seer (SEER), Nevro (NVRO), Nanobiotix (NBTX), Jin Medical International (ZJYL), Biomea Fusion (BMEA), Inotiv (NOTV), and XBiotech (XBIT). These companies are all part of the "medical" sector.

IMAC vs.

FitLife Brands (NASDAQ:FTLF) and IMAC (NASDAQ:IMAC) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.

IMAC received 69 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 60.17% of users gave IMAC an outperform vote while only 50.00% of users gave FitLife Brands an outperform vote.

CompanyUnderperformOutperform
FitLife BrandsOutperform Votes
2
50.00%
Underperform Votes
2
50.00%
IMACOutperform Votes
71
60.17%
Underperform Votes
47
39.83%

FitLife Brands has higher revenue and earnings than IMAC.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FitLife Brands$62.76M2.20$5.30M$1.6917.76
IMAC$15.22M2.21-$10.54MN/AN/A

FitLife Brands has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500. Comparatively, IMAC has a beta of -0.88, meaning that its share price is 188% less volatile than the S&P 500.

2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 24.3% of IMAC shares are held by institutional investors. 61.3% of FitLife Brands shares are held by company insiders. Comparatively, 10.0% of IMAC shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

FitLife Brands has a net margin of 13.38% compared to IMAC's net margin of -75.40%. FitLife Brands' return on equity of 28.03% beat IMAC's return on equity.

Company Net Margins Return on Equity Return on Assets
FitLife Brands13.38% 28.03% 15.13%
IMAC -75.40%-52.17%-34.51%

FitLife Brands currently has a consensus price target of $40.00, suggesting a potential upside of 33.29%. Given FitLife Brands' stronger consensus rating and higher possible upside, research analysts clearly believe FitLife Brands is more favorable than IMAC.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FitLife Brands
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50
IMAC
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, FitLife Brands had 1 more articles in the media than IMAC. MarketBeat recorded 3 mentions for FitLife Brands and 2 mentions for IMAC. FitLife Brands' average media sentiment score of 1.59 beat IMAC's score of 0.00 indicating that FitLife Brands is being referred to more favorably in the media.

Company Overall Sentiment
FitLife Brands Very Positive
IMAC Neutral

Summary

FitLife Brands beats IMAC on 13 of the 17 factors compared between the two stocks.

Get IMAC News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IMAC vs. The Competition

MetricIMACSpecialty Outpatient Clinics IndustryMedical SectorNASDAQ Exchange
Market Cap$33.62M$17.21M$5.26B$8.79B
Dividend YieldN/AN/A5.07%4.00%
P/E RatioN/AN/A86.5116.98
Price / Sales2.212.211,078.91115.09
Price / CashN/AN/A43.2137.77
Price / Book1.841.845.044.89
Net Income-$10.54M-$10.54M$122.31M$228.32M
7 Day Performance-3.09%-3.09%-4.55%-3.67%
1 Month Performance4.06%4.06%-0.82%0.04%
1 Year Performance-43.83%-43.83%24.59%13.79%

IMAC Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IMAC
IMAC
N/A$1.27
-2.3%
N/A-43.8%$33.62M$15.22M0.00106
FTLF
FitLife Brands
4.5727 of 5 stars
$31.68
-1.1%
$40.00
+26.3%
+54.0%$145.67M$62.76M18.7520Short Interest ↓
Positive News
Gap Up
CGEN
Compugen
2.7193 of 5 stars
$1.61
+0.3%
$4.00
+149.2%
+10.6%$143.23M$59.85M80.2568Analyst Forecast
News Coverage
SAVA
Cassava Sciences
4.3571 of 5 stars
$2.97
+2.8%
$111.50
+3,654.2%
-89.6%$142.89MN/A-2.1530
SEER
Seer
1.8268 of 5 stars
$2.41
-2.4%
$3.00
+24.5%
+29.6%$142.11M$14.18M-1.85160News Coverage
NVRO
Nevro
2.6925 of 5 stars
$3.79
+2.2%
$6.30
+66.2%
-77.8%$142.02M$419.15M-2.011,215News Coverage
NBTX
Nanobiotix
3.164 of 5 stars
$3.00
flat
$12.00
+300.0%
-63.1%$141.40M$36.22M0.00100Short Interest ↓
Gap Up
ZJYL
Jin Medical International
N/A$0.91
-10.2%
N/A-98.9%$140.59M$20.13M0.00245Short Interest ↑
News Coverage
Gap Up
BMEA
Biomea Fusion
2.8436 of 5 stars
$3.87
+3.8%
$39.36
+917.1%
-72.7%$140.25MN/A-0.9750Analyst Forecast
News Coverage
NOTV
Inotiv
3.6465 of 5 stars
$5.37
+6.8%
$5.92
+10.2%
+4.2%$139.70M$490.74M-1.282,075Short Interest ↓
Gap Up
XBIT
XBiotech
0.9683 of 5 stars
$4.54
+2.7%
N/A-23.0%$138.39M$4.01M-4.20100News Coverage
Gap Up

Related Companies and Tools


This page (NASDAQ:IMAC) was last updated on 1/14/2025 by MarketBeat.com Staff
From Our Partners